Literature DB >> 7483778

Hybrid genes over-express pertactin from Bordetella pertussis.

S M Loosmore1, R K Yacoob, G R Zealey, G E Jackson, Y P Yang, P S Chong, J M Shortreed, D C Coleman, J D Cunningham, L Gisonni.   

Abstract

Pertactin is a surface adhesin of Bordetella pertussis which is produced in small quantities when expressed from the native prn promoter. Hybrid genes were constructed in which the prn promoter was replaced by either the fha or tox promoter. Recombinant B. pertussis strains containing chromosomally integrated hybrid tox promoter/prn (toxpprn) or fha promoter/prn (fhapprn) genes expressed pertactin at approximately 5- and 8-fold the wild-type level, respectively. The pertactin was correctly processed and secreted and was biochemically and antigenically comparable to its wild-type counterpart, as determined by N-terminal sequence analysis, immunoblotting, peptide mapping, circular dichroism and antigenicity studies. In an adherence assay, a strain over-expressing pertactin was no more adherent than the wild-type strain, but a pertactin-deficient strain was less adherent.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7483778     DOI: 10.1016/0264-410x(94)00015-f

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  6 in total

1.  Differential T- and B-cell responses to pertussis in acellular vaccine-primed versus whole-cell vaccine-primed children 2 years after preschool acellular booster vaccination.

Authors:  Rose-Minke Schure; Lotte H Hendrikx; Lia G H de Rond; Kemal Oztürk; Elisabeth A M Sanders; Guy A M Berbers; Anne-Marie Buisman
Journal:  Clin Vaccine Immunol       Date:  2013-07-03

2.  Identification of pertussis-specific effector memory T cells in preschool children.

Authors:  Lia de Rond; Rose-Minke Schure; Kemal Öztürk; Guy Berbers; Elisabeth Sanders; Inonge van Twillert; Maria Carollo; Françoise Mascart; Clara M Ausiello; Cecile A C M van Els; Kaat Smits; Anne-Marie Buisman
Journal:  Clin Vaccine Immunol       Date:  2015-03-18

3.  T-cell responses before and after the fifth consecutive acellular pertussis vaccination in 4-year-old Dutch children.

Authors:  Rose-Minke Schure; Lotte H Hendrikx; Lia G H de Rond; Kemal Oztürk; Elisabeth A M Sanders; Guy A M Berbers; Anne-Marie Buisman
Journal:  Clin Vaccine Immunol       Date:  2012-09-26

4.  Construction of Bordetella pertussis strains with enhanced production of genetically-inactivated Pertussis Toxin and Pertactin by unmarked allelic exchange.

Authors:  Wasin Buasri; Attawut Impoolsup; Chuenchit Boonchird; Anocha Luengchaichawange; Pannipa Prompiboon; Jean Petre; Watanalai Panbangred
Journal:  BMC Microbiol       Date:  2012-04-23       Impact factor: 3.605

5.  Production and characterization of recombinant pertactin, fimbriae 2 and fimbriae 3 from Bordetella pertussis.

Authors:  Yinghua Xu; Yaying Wang; Yajun Tan; Huajie Zhang; Lijie Wu; Lichan Wang; Qiming Hou; Shumin Zhang
Journal:  BMC Microbiol       Date:  2009-12-29       Impact factor: 3.605

6.  Pertussis circulation has increased T-cell immunity during childhood more than a second acellular booster vaccination in Dutch children 9 years of age.

Authors:  Rose-Minke Schure; Lia de Rond; Kemal Oztürk; Lotte Hendrikx; Elisabeth Sanders; Guy Berbers; Anne-Marie Buisman
Journal:  PLoS One       Date:  2012-07-31       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.